Exabis Library
Welcome to the e-CCO Library!
P021: An electrochemiluminescence (ECL) immunoassay for the detection of antidrug antibodies against anti-mucosal addressin cell adhesion molecule (MAdCAM) monoclonal antibody SHP647
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P021: Aryl hydrocarbon receptor controls ILC3/ILC1 immunity in a colitis model of 2, 4,6-trinitrobenzene sulphonic acid
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P021: Circulating inflammatory protein and cellular profiles at time of diagnosis classify inflammatory bowel disease patients according to their underlying immune response and clinical disease course
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P021: Inflammatory monocytes are key regulators of colonic inflammation in murine and human IBD
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P021: Microbial metabolite receptors as mediators of pathogenic processes in Inflammatory Bowel Disease.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P021: Utility of therapeutic anti-TNF drug monitoring in hospitals with different degree of experience in the treatment of inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P021: Vitamin D receptor-dependent protective effect of moderate hypoxia in a mouse colitis model Running title: Hypoxia prevents mouse colitis through VDR
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P022 Impact of increasing disease symptom concordance between patients with inflammatory bowel disease and their physicians: insights from US, France, Germany, Italy, Spain and UK (5EU)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P022: A correlation of serum Fibroblast Growth Factor 21 level with inflammatory markers and indicators of nutritional status in patients with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P022: Galectin-3, galectin-9, and galectin-3 binding protein in patients with inflammatory bowel diseases
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P022: MET deletion in MRP8+ neutrophils is protective during DDS-induced colitis via Th17 pathway
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P022: Parthenolide enhances the efficacy of anti-tumour effect of balsalazide in human colon cancer cells and colitis-associated colorectal cancer by blockade of NF-kB activation
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P022: Pathologic involvement of the farnesoid X receptor/fibroblast growth factor 19 axis to the Crohn’s disease early postsurgical recurrence.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P022: Severe disease activity in UC is associated with mucosal hypoxia measured endoscopically
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P022: Transcriptional biomarkers for vedolizumab therapy response in patients with moderate to severe Ulcerative Colitis.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P023 Identification of regulated mechanistic pathways and genes to protect intestinal barrier injury by larazotide acetate in an IBD microenvironment
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P023: A resting state fMRI study in patients with active Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P023: Development of methods to investigate effects of narrow spectrum kinase inhibitors on cellular phosphorylation of kinase substrates
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P023: Fatigue in quiescent inflammatory bowel disease is associated with low GM-CSF levels and metabolomic alterations
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P023: Immune-metabolic profiles of creeping fat in relation to degree of severity in Crohn's disease postsurgical recurrence.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM